Peptide Compounding Vote Tracker

Note: These are advisory-committee recommendations, not final FDA rules. The FDA is not required to follow the committee's vote; a substance's actual compounding status is set through later agency rulemaking. Counts and member votes were transcribed from meeting-room photos and the live webcast and may contain minor errors — Day-2 results (Emideltide, Epitalon) are marked provisional pending the FDA transcript. Member profiles and industry-ties tiers are compiled from the cited public sources with per-member confidence levels. Verify against the official FDA record before relying on any of it.